Rx · PZN 10397470, 10397493, 10397501, 10397518
LEVODOPA-Carbidopa-ratiopharm 100 mg/25 mg prolonged-release tablets
German trade nameLEVODOPA Carbidopa-ratiopharm 100 mg-25 mg Retardtabletten
Consistently available
9.6out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
LEVODOPA-Carbidopa-ratiopharm 100 mg/25 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsLEVODOPA-Carbidopa-ratiopharm 100 mg/25 mg prolonged-release tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Prolonged-release tablets. 4 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 8.3 to 9.6 out of 10. The best-available pack was consistently available.
Pack sizes · 4 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 10397518 | 9.4 | 9.6 | ~ €37 |
| 10397501 | 9.3 | 9.5 | ~ €19 |
| 10397470 | 9.4 | 9.2 | ~ €6 |
| 10397493 | 8.2 | 8.3 | ~ €12 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch